Article
Requirement of gp130 signaling for the AGM hematopoiesis.
Experimental hematology - 1 Apr 2003
Takizawa Makiko, Nobuhisa Ikuo, Igarashi Katsuhide, Ueno Masaya, Nakashima Kinichi, Kitamura Toshio, Taga Tetsuya
Abstract excerpt
OBJECTIVE: Definitive hematopoiesis starts in the aorta-gonad-mesonephros (AGM) region during mouse development and remarkably expands in the liver at a later stage of ontogeny. gp130 is a signal transducing receptor component shared by all the IL-6 family cytokines, whose gene ablation in mouse results in the significant reduction in the fetal liver hematopoiesis. The present study aims to evaluate the role of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
